These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3934926)

  • 21. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours.
    Carr DH; Brown J; Bydder GM; Weinmann HJ; Speck U; Thomas DJ; Young IR
    Lancet; 1984 Mar; 1(8375):484-6. PubMed ID: 6142210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.
    Davis PC; Hudgins PA; Peterman SB; Hoffman JC
    AJNR Am J Neuroradiol; 1991; 12(2):293-300. PubMed ID: 1902031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection.
    Bird CR; Drayer BP; Medina M; Rekate HL; Flom RA; Hodak JA
    Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
    Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
    Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MR findings of metastatic brain tumors].
    Tsuchiya K; Makita K; Irie T; Wada Y; Takenaka E
    Rinsho Hoshasen; 1989 Oct; 34(11):1371-6. PubMed ID: 2601101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of contrast agents in CT and MRI (NMR): their potential in imaging of brain tumors.
    Claussen C; Laniado M; Kazner E; Schörner W; Felix R
    Neuroradiology; 1985; 27(2):164-71. PubMed ID: 3990949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Brain Tumor Contrast-enhancement on T1-CUBE and 3D-SPGR Images.
    Majigsuren M; Abe T; Kageji T; Matsuzaki K; Takeuchi M; Iwamoto S; Otomi Y; Uyama N; Nagahiro S; Harada M
    Magn Reson Med Sci; 2016; 15(1):34-40. PubMed ID: 26104076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spin echo and inversion recovery sequences for gadolinium-DTPA enhanced magnetic resonance imaging of intracranial tumors.
    Laniado M; Niendorf HP; Schörner W; Felix R
    Acta Radiol Suppl; 1986; 369():469-71. PubMed ID: 2980530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective enhancement of experimental rat brain tumors with Gd-TPPS.
    Bockhorst K; Els T; Hoehn-Berlage M
    J Magn Reson Imaging; 1994; 4(3):451-6. PubMed ID: 8061446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gadolinium-DTPA in the assessment of liver tumours by magnetic resonance imaging.
    Carr DH; Graif M; Niendorf HP; Brown J; Steiner RE; Blumgart LH; Young IR
    Clin Radiol; 1986 Jul; 37(4):347-53. PubMed ID: 3731701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain tumors: MR imaging with gadolinium-DTPA.
    Felix R; Schörner W; Laniado M; Niendorf HP; Claussen C; Fiegler W; Speck U
    Radiology; 1985 Sep; 156(3):681-8. PubMed ID: 4040643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
    Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
    J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI of high-grade glial tumors: correlation between the degree of contrast enhancement and the volume of surrounding edema.
    Pronin IN; Holodny AI; Petraikin AV
    Neuroradiology; 1997 May; 39(5):348-50. PubMed ID: 9189880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia.
    Davis WK; Boyko OB; Hoffman JM; Hanson MW; Schold SC; Burger PC; Friedman AH; Coleman RE
    AJNR Am J Neuroradiol; 1993; 14(3):515-23. PubMed ID: 8517334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR T1-weighted inversion recovery imaging in detecting brain metastases: could it replace T1-weighted spin-echo imaging?
    Qian YF; Yu CL; Zhang C; Yu YQ
    AJNR Am J Neuroradiol; 2008 Apr; 29(4):701-4. PubMed ID: 18184839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.